PROGRAM CHAIRS
David R. Staskin, MD
Associate Professor of Urology
Tufts University School of Medicine
St. Elizabeth’s Medical Center
Boston, Massachusetts
David O. Sussman, DO, FACOS
Clinical Associate Professor, Department of Surgery
Division of Urology
Section Head, Female Urology and Voiding
Rowan University
Glassboro, New Jersey
PROGRAM OVERVIEW
This program is designed to provide urologists and advanced practice providers in primary care with evidence-based strategies for managing overactive bladder (OAB) in patients receiving treatment for benign prostate hyperplasia (BPH), including an in-depth review of the latest clinical advances in pharmacotherapies, managing treatment-related adverse events, and integrating clinical guideline recommendations into treatment plans. A vivid whiteboard animation depicts the disease state, mechanisms of targeted pharmacotherapies, and associated clinical evidence for learners to explore and gain the knowledge to drive treatment selections more effectively.
TARGET AUDIENCE
This educational activity is intended for urologists and advanced practice providers (APPs) involved in the management of patients with benign prostatic hyperplasia (BPH) and overactive bladder syndrome (OAB).
LEARNING OBJECTIVES
- Interpret recent clinical evidence on emerging pharmacologic treatments for BPH and OAB
- Apply knowledge of available guidelines to select appropriate pharmacologic treatments for patients with BPH and OAB to optimize patient outcomes in urology practice
- Develop effective management strategies to minimize complications with AEs associated with BPH and OAB treatments to improve patient safety and adherence
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| David R. Staskin, MD | Reports that he is an investigator, advisor, and speaker for Sumitomo Pharma America. He is also an advisor for Biohaven and Bristol-Myers Squibb. |
| David O. Sussman, DO | Reports that he has received consulting fees from Teleflex. In addition, Dr. Sussman has participated on the Speakers Bureau for AbbVie. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tara Nelson-Mayfield, MD, Medical Director for Med Learning Group, has nothing to disclose.
- Sarah Milano, RN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Jessica Feygin-Samuels, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: May 14, 2025
EXPIRATION DATE: May 14, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
